Letter to the Editor: Comment on GLP-1-based drugs and COVID-19 treatment
| العنوان: | Letter to the Editor: Comment on GLP-1-based drugs and COVID-19 treatment |
|---|---|
| المؤلفون: | Tianru Jin, Mingyao Liu |
| المصدر: | Acta Pharmaceutica Sinica. B Acta Pharmaceutica Sinica B, Vol 10, Iss 7, Pp 1249-1250 (2020) Acta Pharmaceutica Sinica B |
| بيانات النشر: | Chinese Pharmaceutical Association and Institute of Materia Medica, Chinese Academy of Medical Sciences. Production and hosting by Elsevier B.V., 2020. |
| سنة النشر: | 2020 |
| مصطلحات موضوعية: | 2019-20 coronavirus outbreak, endocrine system, Letter to the editor, Coronavirus disease 2019 (COVID-19), business.industry, Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), lcsh:RM1-950, digestive, oral, and skin physiology, MEDLINE, Virology, Article, lcsh:Therapeutics. Pharmacology, Medicine, General Pharmacology, Toxicology and Pharmaceutics, business, hormones, hormone substitutes, and hormone antagonists |
| الوصف: | Highlights • GLP-1R is abundantly expressed in lung epithelia and certain immune cells. • GLP-1 based drugs show “therapeutic effects” in acute and chronic lung injury models. • Clinical trial is designed in testing effect of GLP-1 analogues in treating Covid-19. • Retrospective studies should be conducted in T2D subject with Covid-19. |
| اللغة: | English |
| تدمد: | 2211-3843 2211-3835 |
| URL الوصول: | https://explore.openaire.eu/search/publication?articleId=doi_dedup___::c9dd348deecd75149a3fef411c8c54cf http://europepmc.org/articles/PMC7255283 |
| حقوق: | OPEN |
| رقم الأكسشن: | edsair.doi.dedup.....c9dd348deecd75149a3fef411c8c54cf |
| قاعدة البيانات: | OpenAIRE |
| تدمد: | 22113843 22113835 |
|---|